COLL vs EVRG · P/E 17, rev $181.9M vs P/E 22, rev $5.85B
Collegium Pharmaceutical Inc (COLL) versus Evergy, Inc. (EVRG) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Evergy, Inc. (EVRG) is a utilities - regulated electric company listed on NASDAQ.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported EVRG revenue for 2024-12-31 was $5.85B. Net income was $885.8M. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. EVRG currently screens at market cap $19.10B and trailing P/E 22.0.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. EVRG currently screens at market cap $19.10B and trailing P/E 22.0.
Not investment advice. Open the COLL and EVRG stock pages for the full models.
Not investment advice.